These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6291235)

  • 1. A pH-dependent antigenic conversion of empty capsids of poliovirus studied with the aid of monoclonal antibodies to N and H antigen.
    Rombaut B; Vrijsen R; Brioen P; Boeyé A
    Virology; 1982 Oct; 122(1):215-8. PubMed ID: 6291235
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
    Uhlig H; Haardt F; Dernick R
    Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope evolution in poliovirus maturation.
    Rombaut B; Vrijsen R; Boeyé A
    Arch Virol; 1983; 76(4):289-98. PubMed ID: 6194772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location and primary structure of a major antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
    Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.
    Chow M; Baltimore D
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7518-21. PubMed ID: 6296837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic N to H conversion of poliovirus by a monoclonal antibody at low ionic strength.
    Delaet I; Vrijsen R; Boeyé A
    Virology; 1992 May; 188(1):93-101. PubMed ID: 1314469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intertypic cross-reactions of nonneutralizing, monoclonal poliovirus antibodies.
    Vrijsen R; Rombaut B; Boeye A
    J Virol; 1984 Mar; 49(3):1002-4. PubMed ID: 6199509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hit-and-run neutralization of poliovirus.
    Brioen P; Rombaut B; Boeyé A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disoxaril stabilization and immunogenicity of poliovirus procapsids.
    Rombaut B; Brioen P; Boeyé A
    J Gen Virol; 1990 May; 71 ( Pt 5)():1081-6. PubMed ID: 2161045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase activity in purified poliovirus particles and empty viral capsid preparations.
    Schärli CE; Koch G
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():129-39. PubMed ID: 6319565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.
    Pasamontes L; Egger D; Bienz K
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsid destabilization is required for antibody-mediated disruption of poliovirus.
    Delaet I; Boeyé A
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():581-7. PubMed ID: 8126454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity and immunogenicity of poliovirus capsid proteins.
    van Wezel AL; van der Marel P; Hazendonk TG; Boer-Bak V; Henneke MA
    Dev Biol Stand; 1983; 55():209-15. PubMed ID: 6203795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies that disrupt poliovirus only at fever temperatures.
    Delaet I; Boeyé A
    J Virol; 1993 Sep; 67(9):5299-302. PubMed ID: 8394450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assembly of poliovirus 14 S subunits: disoxaril stabilization as a model for the antigenicity conferring activity of infected cell extracts.
    Rombaut B; Boeyé A
    Virology; 1991 Feb; 180(2):788-92. PubMed ID: 1703372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.